We enter partnerships that make good scientific sense and have strong business value, regardless of modality or technology.

Our Business Development professionals in North America (New Jersey), Europe (Ireland) and China (Nanjing) are dedicated to creating collaborations that are mutually beneficial and have the potential to positively impact the lives of patients.

Our areas of focus for business development are:

  • Innovations in cell therapy
  • Oncology
  • Immune cell biology and engineering

As a partner, we provide end-to-end capabilities for cell therapies from discovery to commercialization.

Comprehensive R&D capabilities

  • High-throughput antibody screening and engineering
  • Proprietary methodologies to optimize CAR-T constructs
  • Pre-clinical validation

Rapidly advancing clinical assets

  • Relationships with leading clinicians to rapidly advance our pipeline and platforms
  • Maintaining focus on quality and compliance throughout clinical development

A global manufacturing network

  • Three manufacturing facilities capable of producing clinical and commercial CAR-T supplies
  • Industry-leading technologies and service providers to innovate the CAR-T manufacturing process, optimize the end-to-end supply chain, and streamline the product delivery model

A best-in-class global commercialization

  • Deep experience in cell therapy commercial strategy and execution
  • End-to-end commercial CAR-T operational excellence
  • Highly specialized commercial sales and educational teams

We’re ready to speak with you.

Please know there is no guarantee that the agents discussed will receive health authority approval or become commercially available in any country for the uses being investigated .
close

You are about to leave LegendBiotech.com

We use cookies to improve your experience on our website, measure performance, understand our audience, for advertising and support purposes. You can always change your preferences or opt out from our use of cookies.